Nasopharyngeal carcinoma results in high patient morbidity and mortality, due to early metastasis, and toxicity due to chemotherapy. Mukonal is plant-derived carbazole alkaloid that has been used in traditional Chinese medicine to treat several types of cancer. This study aimed to investigate the effects of mukonal on cell proliferation, apoptosis, autophagy, and the mitochondrial membrane potential of nasopharyngeal carcinoma cells in vitro.
Background
Nasopharyngeal carcinoma is one of the most prevalent malignant tumors in Southeast Asia and Southern China [1] . This malignancy is associated with high patient morbidity and mortality due to due to early metastasis, and toxicity due to current chemotherapy [1] . The five-year survival rate, using combined treatment with adjuvant cisplatin chemotherapy and radiotherapy, is between 50-60% [2] . The constant relapses and distant metastasis of nasopharyngeal carcinoma make it difficult to manage with current treatment strategies [3] .
Current treatment for nasopharyngeal carcinoma includes surgical excision, systemic chemotherapy, or local radiotherapy. However, owing to the adverse effects of some treatments, patient quality of life is can be impaired [4] . Drug treatment derived from natural sources have recently been studied, and have included studies to identify and screen anticancer molecules from natural resources [5] . Also, the advent of in silico technology has recently helped to identify natural bioactive molecules from the vast libraries of natural products [6] . Based on the structure of their metabolites, herbal-derived therapeutic agents have been classified, and carbazole alkaloids have recently received attention due to their pharmacological potential [7] .
Carbazole alkaloids have been shown to have anticancer effects [8] . Mukonal, a carbazole alkaloid derived from Clausena guillauminii has recently been shown to have anticancer effects in different types of cancer [9] . Mukonal has been reported to induce apoptosis and cell cycle arrest of laryngeal cancer cells [9] . Therefore, this study aimed to investigate the effects of mukonal on cell proliferation, apoptosis, autophagy, and the mitochondrial membrane potential of CNE1 nasopharyngeal carcinoma cells in vitro.
Material and Methods
Reagents, cell lines, and cell culture Mukonal, which was determined to be 98% pure by high-performance liquid chromatography (HPLC), and other chemicals were obtained from Sigma-Aldrich (Sigma-Aldrich, St. Louis MO, USA), unless otherwise stated. The human nasopharyngeal carcinoma cell line, CNE1 and the normal NP69 cell lines were obtained from the Type Culture Collection of Chinese Academy of Sciences (Shanghai, China). RPMI-1640 cell culture media was used, which also contained fetal bovine serum (FBS) (Thermo Fisher Scientific Inc., Waltham, MA, USA) (10%) and appropriate antibiotics (streptomycin 100 μg/ml and penicillin G 100 U/ml). The cultures were maintained in an atmosphere containing 5% CO 2 at 37°C.
Cell viability assay
Briefly, at around 70% confluence the CNE1 and the NP69 cells were seeded in 96-well plates and treated with 0-320 µM of mukonal. After incubation for 24 h, the cells were incubated with MTT for 4 h. Then, the media was removed and the colored formazan product was solubilized by 200 µl of dimethyl sulfoxide (DMSO). The viability of the CNE1 and the NP69 cells was then determined by absorbance measurements at 570 nm.
Determination of reactive oxygen species (ROS), mitochondrial membrane potential, and cytochrome C The ROS and mitochondrial membrane potential levels were estimated by culturing the CNE1 cells for 24 at 37°C, followed by treatment with increasing doses of mukonal (0, 4.5, 9, and 18 µM) for 24 h. The media was decanted and the cells were treated with 5 µM 2',7'-dichlorofluorescein diacetate (DCH-DA) for estimation of ROS, or rhodamine 123 (Rh123) for estimation of mitochondrial membrane potential, by examination of the cells using laser scanning confocal microscopy. Cytochrome C levels were investigated by immunofluorescence microscopy, as previously described [10] .
Fluorescence nuclear staining with 4',6-diamidino-2-phenylindole (DAPI) CNE1 cells were grown in 6-well plates (0.6×10 6 cells/well) and incubated for 12 h. CNE1 cells were treated with increasing doses of mukonal (0, 4.5, 9, and 18 µM) for 24 h at 37°C. As the cells became non-adherent, 25 μl of cell cultures were placed onto glass slides and stained with DAPI. The slides were then covered with a coverslip and examined with a fluorescence microscope.
Transmission electron microscopy (TEM)
For electron microscopy, the cells were fixed in the solution of 4% glutaraldehyde 0.05 M sodium cacodylate, post-fixed in 1.5% osmium tetroxide (OsO 4 ), and dehydrated in alcohol. The cells were then prepared for embedding in Epon 812, sectioned, and then observed using a Zeiss CEM 902 electron microscope (Zeiss, Oberkochen, Germany).
Cell cycle analysis
After incubating the CNE1 human nasopharyngeal carcinoma cells with increasing concentrations of mukonal (0, 4.5, 9, and 18 µM) for 24 h. The cells were washed with phosphate buffered saline (PBS). The cells were stained with propidium iodide (PI) and the distribution of the cells in the phases of the cell cycle phases was assessed by fluorescence-activated cell sorting (FACS) flow cytometry. 
Western blot
The CNE1 cells were harvested and washed with ice-cold PBS. The cell pellet was then resuspended in a lysis buffer at 4°C and then at 95°C. The protein content of each cell extract was measured using the Bradford spectroscopic assay. About, 40 µg of protein was loaded from each sample and separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) before being transferred to a polyvinylidene fluoride (PVDF) membrane. The membranes were then washed with TBS and then incubated at 4°C in primary antibodies to caspase-3, caspase-9, Bax, Bcl-2, PCNA, cell division cycle 25C (CDC25C), pCDC25C, CDC2, pCDC2, and cyclin B1. The membranes were incubated with appropriate secondary antibodies and the proteins of interest were visualized by enhanced chemiluminescence (ECL).
Statistical analysis
Data were presented as the mean ± standard deviation (SD). Statistical significance and IC 50 values were analyzed using GraphPad Prism Demo, Version 5 (GraphPad Software, Inc., San Diego, CA, USA). Student's t-test was used for comparison between two samples, and one-way analysis of variance (ANOVA) followed by Tukey's test was used for comparisons between more than two samples. A P-value <0.05 was considered to be statistically significant. 
Results
Mukonal inhibited the proliferation of CNE1 nasopharyngeal carcinoma cells
The growth inhibitory effects of mukonal ( Figure 1A ) were examined on the CNE1 nasopharyngeal carcinoma and the normal NP69 cells by the MTT assay at concentrations ranging from 0 to 320 µM. Mukonal was found to inhibit the growth of the CNE1 cells in a dose-dependent way ( Figure 1B) . The IC 50 of mukonal for the CNE1 cells was found to 9 µM. However, the effects of mukonal on the proliferation of the NP69 cells was negligible. The IC 50 of mukonal on the normal NP69 cells was 80 µM ( Figure 1B) .
Mukonal induced apoptotic cell death of CNE1 nasopharyngeal carcinoma cells via reactive oxygen species (ROS)-mediated mitochondrial disruption
The levels of ROS and the mitochondrial membrane potential were measured in the CNE1 nasopharyngeal carcinoma cells, and mukonal treatment resulted in the production of large amounts of ROS, and also resulted in the disruption of the mitochondrial membrane potential (Figure 2 ). Mukonal treatment resulted in the release of cytochrome C in the NCE1 cells ( Figure 3) . Apoptosis in the mukonal-treated CNE1 cells was determined by fluorescence staining using DAPI, which showed that the percentage of apoptotic cells increased with increasing concentrations of mukonal ( Figure 4) . Apoptosis of the mukonal-treated CNE1 cells was further validated by examining the levels of apoptosis-related proteins by Western blot analysis. Mukonal treatment increased the levels of cleaved caspase-3 and caspase-9 in a dose-dependent manner. The expression of Bax was increased, and the expression of Bcl-2 and PCNA were decreased following mukonal treatment ( Figure 5 ).
Mukonal induced autophagy in CNE1 cells
Electron microscopy was used to further investigate the effects of mukonal on autophagy in the CNE1 cells, and the findings showed that mukonal treatment resulted in the formation of autophagic vesicles in the CNE1 nasopharyngeal carcinoma cells, and this occurred in a dose-dependent manner ( Figure 6 ). Also, mukonal treatment enhanced the expression of LC3 II and beclin-1 and decreased the expression of p62, supporting mukonal-induced autophagy ( Figure 7 ).
Mukonal arrested the CNE1 cells at the G2/M phase of the cell cycle
The distribution of the cycle phase of CNE1 cells was assessed by flow cytometry at concentrations of 0, 9, 18, and 36 µM of mukonal. The percentage of cells in the G2/M phase increased significantly from 6.6% in the untreated cells to 34.0% at a concentration of 36 µM of mukonal ( Figure 8 ). The arrest of the CNE1 cells at the G2/M phase was associated with changes in the expression of several of the cell cycle-associated proteins. The protein expression of CDC25C, pCDC25C, CDC2, pCDC2, and cyclin B1 were decreased following mukonal treatment ( Figure 9 ). 
Discussion
Nasopharyngeal carcinoma is a common head and neck malignancy [11] . The early metastasis of nasopharyngeal carcinoma and the adverse effects of current treatment strategies are the main obstacles that limit the effectiveness of treatment [12] . Plants serve as a diverse repository of chemicals that may prove to be essential for the development of safer chemotherapy for the treatment of nasopharyngeal carcinoma [13] .
In this study, the anticancer effects of mukonal, a plant-derived carbazole alkaloid, were studied in CNE1 human nasopharyngeal carcinoma cells and NP69 normal nasopharyngeal epithelial cells. Mukonal treatment resulted in dose-dependent effects on the CNE1 cells, with minimal toxic effects. These results are in agreement with previous studies that have shown that alkaloids inhibit the growth of cancer cells [14] . Also, mukonal has previously been shown to inhibit the growth of laryngeal cancer cells, which is a finding that supports the results of this study [9] . The results of this study showed that mukonal caused the accumulation of significant amounts of reactive oxygen species (ROS) that resulted in the disruption of the mitochondrial membrane potential and triggered the release of cytochrome C in CNE1 nasopharyngeal carcinoma cells. Mukonal treatment was associated with apoptosis, which was shown by fluorescence staining of the cell nuclei with 4',6-diamidino-2-phenylindole (DAPI), as well as the expression of apoptosisassociated proteins in CNE1 cells. Also, mukonal treatment induced autophagy of the nasopharyngeal carcinoma CNE1 cells and triggered the G2/M arrest in a dose-dependent manner.
Plant-derived molecules have been reported to affect ROS levels in the cancer cells [15] . In the present study, mukonal was shown to trigger the formation ROS in CNE1 cells, which was accompanied by the disruption of the mitochondrial membrane potential, which has previously been reported to be associated with the release of cytochrome C [16] . The findings of this study also showed that mukonal treatment resulted in the release of cytochrome C in the CNE1 cells. Because apoptosis is an important mechanism in the control of cancer growth and in the maintenance of tissue homeostasis, and mukonal has been shown to be associated with apoptotic cell death in the laryngeal carcinoma cells [9, 17] , this study included DAPI staining of the mukonal treated-CNE1 cells, which confirmed the effect of mukonal on apoptosis.
In this study, mukonal-induced apoptosis was accompanied by an increase in caspases and Bax and a decrease in Bcl-2 and PCNA. Previous studies have shown that carbazole alkaloids have been shown to induce autophagy in cancer cells. Isomahanine, a carbazole alkaloid, has been reported to activate autophagy in oral carcinoma cells [18] . Therefore, in this study, mukonal-treated CNE1 cells were examined by electron microscopy and resulted in the formation of autophagic vesicles in the CNE1 cells. Also, mukonal treatment upregulated the expression of LC3 II and beclin-1, which are markers of autophagy. Mukonal treatment also arrested CNE1 cells in the G2/M phase in a dose-dependent manner. These findings are supported by the findings from studies on similar molecules, such as mahanimbine, which has been reported to trigger cell cycle arrest [19] . The results of the present study suggest that further studies, including in vitro and in vivo studies, and controlled clinical studies, are required to evaluate the potential role of mukonal in the management of nasopharyngeal cancer.
Conclusions
Mukonal inhibited the growth of CNE1 nasopharyngeal carcinoma cells in vitro without toxicity and triggered apoptosis, autophagy, and cell cycle arrest of the CNE1 cells via reactive oxygen species (ROS)-mediated alterations in the mitochondrial membrane potential. These findings support the need for further in vitro and clinical studies to determine the potential role for mukonal as a natural treatment for nasopharyngeal carcinoma.
